Navigation Links
AquaMax DW4 from Molecular Devices

ProductsAquaMax DW4 from Molecular Devices
Company Molecular Devices
Item AquaMax DW4
Price 
Description The AquaMax DW4 liquid handling system from Molecular Devices provides precise dispensing and thorough washing all in one instrument. The system handles a variety of plate formats for dispensing and plate washing96-, 384- and 1536-welland is the first to handle 1536-well microplate washing. AquaMax DW4 has been optimized to dispense from four different channels to accommodate up to four fluids.

unique design
The AquaMax DW4 systems small footprint houses a built-in vacuum and air pressure pump. No external vacuum system is needed. Each of the four separate reservoir bottles have their own fluid path to individual dispense heads, providing the system with the ability to dispense four different fluids into one microplate. A magnetic stirring mechanism is housed in the manifold to allow mixing of solutions in the first inlet reservoir bottle. (See Figure 1.) The system is robotic-compatible with a robotic-friendly plate carriage and accessible RS-232 COM port.

flexibility
The flexibility of the instrument is evident with the Windows-compatible software. The software is bi-directional and allows the user to view what is currently on the instrument, as well as set up new programs. Row selection offers the choice to dispense from a few rows or the complete plate. The software provides for the adjustment of liquid factor and aspiration probe height to allow for low residual volume, as well as configuration of users and microplates.

versatility
The system can be configured with up to four dispense heads and one aspirate head. The liquid handling system accommodates 96-, 384- and 1536-well microplate formats. The system has a separate set of optimized heads to handle each plate type.

usability
The AquaMax DW4 is a non-contact, fixed-tip dispenser and washer. The dispense and aspirate heads, working with the software, determine the configuration that ranges from 96- to 1536-well formats.

Info Molecular DevicesMolecular Devices
1311 Orleans Avenue
Sunnyvale CA 94089-1136
U.S.A.


Call Molecular Devices to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-853-2567
Customer Service: 800-635-5577
Fax Number: 408-747-3601
Web Site: http://www.moleculardevices.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. AquaMax DW4 from Molecular Devices
2. Cleland’s Reagent, Molecular Biology Grade from Calbiochem
3. SYBR Green II RNA gel stain*10,000X concentrate in DMSO* from Molecular Probes (Invitrogen)
4. SYBR Green II RNA gel stain*10,000X concentrate in DMSO* from Molecular Probes (Invitrogen)
5. SYBR Green II RNA gel stain*10,000X concentrate in DMSO**special packaging* from Molecular Probes (Invitrogen)
6. GenePix Pro Microarray Image Analysis Software from Molecular Devices
7. adenosine 5-O-(3-thiotriphosphate), BODIPY FL conjugated/tagged from Molecular Probes (Invitrogen)
8. Acuity Enterprise Microarray Informatics Software from Molecular Devices
9. SlowFade Antifade Kit from Molecular Probes (Invitrogen)
10. SYBR Green I nucleic acid gel stain*10,000X concentrate in DMSO* from Molecular Probes (Invitrogen)
11. SYBR Green I nucleic acid gel stain*10,000X concentrate in DMSO**special packaging* from Molecular Probes (Invitrogen)
(Date:6/11/2015)... , June 11, 2015 Daon, ... announced today that its IdentityX Mobile Authentication Platform ... IDentity Online) Alliance is an industry consortium launched ... standards for simpler, stronger authentication.  In order to ... pass a rigorous series of tests that measure ...
(Date:6/9/2015)... , June 9, 2015   MedNet Solutions ... the entire spectrum of clinical research, will be providing ... technology platform at the 2015 Drug Information Association (DIA) ... on June 15-17.  These presentations will include previews of ... out in the upcoming iMedNet 2015 Feature ...
(Date:6/8/2015)... , June 8, 2015  Trovagene, Inc. (NASDAQ: TROV ... clinical data featuring its Precision Cancer Monitoring SM platform ... Liquid Biopsies conference in San Diego, CA ... Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy ... June 13-16. "We continue to advance our ...
Breaking Biology News(10 mins):Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 2Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 4
... populating the growing brain, neural stem cells must strike a ... the cells multiply to provide plenty of starting materials ... If the stem cells proliferate too much, they could ... proliferate too little, there may not be enough cells to ...
... / b3c newswire / - KINAXO Biotechnologies GmbH ... service portfolio. KinAffinity provides invaluable information about a ... of interest. It simultaneously determines affinities for native ... overcomes the limitations of traditional biochemical assays that ...
... of researchers from the University of Maryland Center for ... study to forecast the effects of environmental change on ... by a $620,000 grant from the National Science Foundation, ... Preserve near Alexandria, Virginia. "Freshwater marshes are integral ...
Cached Biology News:UNC study pinpoints gene controlling number of brain cells 2KINAXO launches KinAffinity services for efficient profiling of kinase inhibitors in cells or tissue 2
(Date:7/2/2015)... 2015  Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual ... of intellectual property, today announced a litigation update. ... Verizon Services Corp. et al. , Case No. 1:14-cv-00721-GBL-TCB, ... District of Virginia , the Court ... certain key claims in favor of the Defendants on ...
(Date:7/2/2015)... Memphis, TN (PRWEB) , ... July 02, 2015 ... ... in the development and manufacturing of surgical instruments in Orthopedics, announced today the ... orthopedic contract-manufacturing and the world's largest provider of surgical instruments to the Spine ...
(Date:7/1/2015)... 1, 2015   Decision Resources Group ... of Otezla are its oral administration, alternative mechanism ... by surveyed rheumatologists. Otezla was the first oral ... of active psoriatic arthritis in the ... care includes conventional oral treatments including disease-modifying antirheumatic ...
(Date:7/1/2015)... , July 1, 2015   Neuraltus ... the development of groundbreaking drugs to treat neurodegenerative ... today that Robert G. Miller , M.D., Director ... Sutter Health,s California Pacific Medical Center in San Francisco, ... Association for $1.5 million to help fund a ...
Breaking Biology Technology:Spherix Issues A Litigation Update 2Spherix Issues A Litigation Update 3In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4